COVID19 reagent
Ended Awarded Last action
- Contract number
- N6264521F0206
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $399,410
Award facts
- Opportunity
-
- Covid-19 Solicitation · N6264520Q0017 · Posted May 12, 2020
- Contract value 100% obligated
- $399,410.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $399,410 |
About this award
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for the provision of COVID-19 reagents. The contract, which does not have a set-aside designation, has a ceiling value of $399,410.00 and a period of performance through September 30, 2021. Gen-Probe, which specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government, has held numerous contracts with defense and civilian agencies to supply testing kits, reagents, and equipment for detecting infectious diseases, including COVID-19. This award is associated with the Coronavirus COVID-19 national interest action and reflects Gen-Probe's position as a key supplier of critical medical diagnostic products to support ongoing healthcare and pandemic response efforts for military personnel, veterans, and their families.
Quick answers
Who was awarded contract N6264521F0206?
N6264521F0206 was awarded to Gen-Probe Incorporated by Bureau of Medicine and Surgery (Department of the Navy) on July 12, 2021.
How much is contract N6264521F0206 worth?
The government has obligated $399,410 on N6264521F0206.
Which agency awarded contract N6264521F0206?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6264521F0206, with funding from Defense Health Agency (Department of Defense).
Is contract N6264521F0206 an order under another contract?
Yes. N6264521F0206 is a delivery order under N6264520D5007, an indefinite delivery contract.
Was contract N6264521F0206 competed?
The extent of competition for N6264521F0206 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award